sotalol has been researched along with Recrudescence in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (12.79) | 18.7374 |
1990's | 31 (36.05) | 18.2507 |
2000's | 35 (40.70) | 29.6817 |
2010's | 8 (9.30) | 24.3611 |
2020's | 1 (1.16) | 2.80 |
Authors | Studies |
---|---|
Hagiwara, A; Hamasaki, T; Horigome, H; Ikeda, T; Inamura, N; Kato, H; Katsuragi, S; Kawataki, M; Maeno, Y; Miyoshi, T; Nii, M; Sago, H; Sakaguchi, H; Shimizu, W; Shiraishi, I; Taketazu, M; Ueda, K; Yamamoto, H; Yasukochi, S; Yoda, H | 1 |
Belli, G; Brambilla, A; Capponi, G; De Simone, L; Favilli, S; Giovannini, M; Porcedda, G; Remaschi, G; Vannuccini, F | 1 |
Balsam, P; Kiliszek, M; Kochanowski, J; Koźluk, E; Lodziński, P; Opolski, G; Piątkowska, A; Piątkowski, R; Scisło, P | 1 |
Aliot, EM; Capucci, A; Connolly, S; Crijns, HJ; Guerra, F; Hohnloser, SH; Kowey, PR; Radzik, D; Roy, D | 1 |
Adelstein, E; Alam, MB; Jain, SK; Khattak, F; Leef, G; Munir, MB; Patel, D; Qin, D; Rattan, R; Saba, S | 1 |
Ermakov, S; Gerstenfeld, EP; Scheinman, MM; Svetlichnaya, Y | 1 |
Abildstrøm, SZ; Andersen, SS; Folke, F; Fosbøl, E; Gislason, GH; Hansen, ML; Køber, L; Madsen, M; Rasmussen, S; Schramm, TK; Sørensen, R; Torp-Pedersen, C | 1 |
Bodalski, R; Maryniak, A; Szufladowicz, E; Szumowski, Ł; Urbanek, P; Walczak, F; Zakrzewska-Koperska, J | 1 |
Hanon, S; Sato, K; Schweitzer, P; Shimada, YJ | 1 |
Strickberger, SA; Venkataraman, G | 1 |
Arya, A; Boodhoo, L; Bordoli, G; Cheek, E; Large, J; Lloyd, GW; Mitchell, A; Patel, NR; Pugh, P; Silberbauer, JS; Sulke, AN; Taggu, W; Vrahimides, J | 1 |
Goodman, IS; Lu, CJ | 1 |
Bosch, RF; Dörnberger, V; Kettering, K; Kühlkamp, V; Mewis, C; Vonthein, R | 1 |
Friberg, J; Gadsbøll, N | 1 |
Lau, CP; Tse, HF | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Yee, R; Zarnke, K | 1 |
Dorian, P; Mangat, I | 1 |
Chlouverakis, GI; Hamilos, ME; Igoumenidis, NE; Klapsinos, NC; Kochiadakis, GE; Tzerakis, PG; Vardas, PE | 1 |
Aizawa, Y; Chinushi, M; Fujita, S; Furushima, H; Hirono, T; Hosaka, Y; Kato, K; Komura, S; Sugiura, H; Tanabe, Y; Washizuka, T; Watanabe, H | 1 |
Boldini, A; Brentana, L; D'Aloia, A; Dei Cas, L; Faggiano, P; Pedrinazzi, C; Procopio, R | 1 |
Scharf, C | 1 |
Ata, N; Birdane, A; Cavusoglu, Y; Goktekin, O; Gorenek, B; Kudaiberdieva, G; Timuralp, B; Unalir, A | 1 |
Frick, M; Nergärdh, A; Nordlander, R | 1 |
Brunckhorst, CB | 1 |
Coleman, CI; Guertin, D; Henyan, NN; Kluger, J; McBride, BF; Min, B; Silver, BB; White, CM | 1 |
Bauman, JL; Kehoe, RF; Leal, S; Mykytsey, A; Razminia, M; Saleem, M; Wang, T; Zheutlin, T | 1 |
Butter, C; Gerhardt, L; Helms, S; Schlegl, M; Stockburger, M | 1 |
Jackson, FS; Julian, DG; Prescott, RJ; Szekely, P | 2 |
Amery, A; Bulpitt, C; Cattaert, A; Fagard, R; Staessen, J; Vanhees, L | 1 |
Goldstein, S | 1 |
Brachmann, J; Czygan, E; Jauernig, R; Kübler, W; Lengfelder, W; Rizos, I; Senges, J | 1 |
Lazzara, R | 1 |
Burattini, M; Carunchio, A; Ceci, V; Fera, MS; Galati, A; Greco, G; Mazza, A | 1 |
Antman, EM; Cantillon, CO; Lamas, GA; Reimold, SC | 1 |
Alboni, P; Chioin, R; Fucà, G; Paparella, N; Pedini, I; Razzolini, R; Scarfò, S | 1 |
Klein, RC | 1 |
Brechenmacher, C; Chauvin, M; Koenig, A; Theolade, R | 1 |
Dunnington, C; Ezri, MD; Kehoe, RF; Lueken, M; MacNeil, DJ; Nazari, J; Spangenberg, RB; Zheutlin, TA | 1 |
Antman, EM; Cantillon, CO; Friedman, PL; Reimold, SC | 1 |
Berman, N; Dorian, P; Hardy, J; Mitchell, J; Newman, D | 1 |
Anderson, K; Joseph, SP; Joy, M; Wanless, RS | 1 |
Burattini, M; Carunchio, A; Ceci, V; Coletta, C; Fera, MS; Galati, A; Mazza, A | 1 |
Beaufort-Krol, GC; Bink-Boelkens, MT | 1 |
Alt, E; Ammer, R; Ayers, GM; Lehmann, G; Pasquantonio, J; Pütter, K; Schömig, A | 1 |
Borggrefe, M; Breithardt, G; Eckardt, L; Haverkamp, W | 1 |
Duytschaever, M; Haerynck, F; Jordaens, L; Tavernier, R | 1 |
Igoumenidis, NE; Kanoupakis, EM; Kochiadakis, GE; Marketou, ME; Solomou, MC; Vardas, PE | 1 |
de Paola, AA; Veloso, HH | 2 |
Anderson, JL; Prystowsky, EN | 1 |
Koch, HP; Lüderitz, B; Meinertz, T; Patten, M; Sonntag, F | 1 |
Bosch, RF; Kühlkamp, V; Mermi, J; Mewis, C; Seipel, L | 1 |
Ayers, GM; Lau, CP; Tse, HF | 2 |
Huang, SK; Lai, LP; Lien, WP; Lin, JL; Tseng, YZ | 2 |
Lewalter, T; Lüderitz, B | 1 |
Kapusta, L; Kleinman, CS; Meijboom, EJ; Michon, MM; Oudijk, MA; Stoutenbeek, P; Visser, GH | 1 |
Darpö, B; Frick, M; Ostergren, J; Rosenqvist, M | 1 |
Aass, H; Kongsgaard, E | 1 |
Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Simantirakis, EN; Vardas, PE | 1 |
Akhtar, M; Cooley, R; Sra, J | 1 |
Klein, GJ; Krahn, AD; Lee, JK; Simpson, C; Skanes, A; Spindler, B; Yee, R; Zarnke, K | 1 |
Chrysostomakis, SI; Igoumenidis, NE; Kaleboubas, MD; Kochiadakis, GE; Marketou, ME; Mavrakis, HE; Vardas, PE | 1 |
Barbosa, EC; Barbosa, PR; Boghossian, SH; da Rocha, PJ; de Souza Bomfim, A; Filho, FM; Ginefra, P | 1 |
Alt, EU; Lehmann, G; Ndrepepa, G; Plewan, A; Schmitt, C; Schömig, A; Schreieck, J | 1 |
Bellandi, F; Dabizzi, RP; Frascarelli, F; Giovannini, T; Leoncini, M; Maioli, M; Simonetti, I | 1 |
Fenrich, AL; Friedman, RA; Kertesz, NJ; Price, JF; Snyder, CS | 1 |
Fetsch, T | 1 |
Bacchi Reggiani, L; Bartolotti, M; Biffi, M; Boriani, G; Branzi, A; Zannoli, R | 1 |
Connolly, SJ; Dorian, P; Green, M; Newman, D; Paquette, M; Roy, D; Talajic, M | 1 |
Borggrefe, M; Breithardt, G; Haverkamp, W; Hindricks, G; Shenasa, M | 1 |
Arstall, MA; Hii, JT; Horowitz, JD; Lehman, RG | 1 |
Crijns, HJ; Gosselink, AM; Hillege, H; Lie, KI; Van Gelder, IC; Van Gilst, WH | 1 |
Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE | 1 |
Edvardsson, N; Juul-Möller, S; Rehnqvist-Ahlberg, N | 1 |
Klein, H; Lichtlen, P; Trappe, HJ | 1 |
Dunnington, CS; Kehoe, RF; Mattioni, TA; Spangenberg, RB; Yu, G; Zheutlin, TA | 1 |
Antman, EM; Beamer, AD; Cantillon, C; Friedman, PL; McGowan, N | 1 |
Gössinger, HD; Leitha, T; Mösslacher, H; Siostrzonek, P; Wagner, L | 1 |
Clement, DL; Jordaens, LJ; Palmer, A | 1 |
Finkelstein, D; Garan, H; Kuchar, DL; McComb, J; McGovern, BA; Rottman, JN; Ruskin, JN; Venditti, FJ | 1 |
Ellis, T; Lebsack, C; Mead, RH; Ruder, MA; Smith, NA; Winkle, RA | 1 |
Bowman, E; Paes, BA; Way, RC | 1 |
Anastasiou-Nana, MI; Anderson, JL; Askins, JC; Gilbert, EM; Menlove, RL; Nanas, JN | 1 |
7 review(s) available for sotalol and Recrudescence
Article | Year |
---|---|
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disopyramide; Electric Countershock; Flecainide; Humans; Propafenone; Quinidine; Recurrence; Sotalol | 1993 |
Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Defibrillators, Implantable; Heart Arrest; Humans; Randomized Controlled Trials as Topic; Recurrence; Sotalol; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |
Sotalol: An important new antiarrhythmic.
Topics: Action Potentials; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Defibrillators, Implantable; Drug Interactions; Electrocardiography; Humans; Randomized Controlled Trials as Topic; Recurrence; Refractory Period, Electrophysiological; Sotalol; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Fibrillation; Ventricular Premature Complexes | 1999 |
Management of atrial flutter.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Electrophysiologic Techniques, Cardiac; Flecainide; Heart Conduction System; Humans; Quality of Life; Recurrence; Sotalol; Treatment Outcome | 2000 |
Is primary antiarrhythmic drug therapy for ventricular arrhythmias obsolete?
Topics: Amiodarone; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantable; Humans; Randomized Controlled Trials as Topic; Recurrence; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1999 |
How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Evaluation; Electric Stimulation; Electrocardiography, Ambulatory; Humans; Prognosis; Recurrence; Sotalol; Tachycardia; Ventricular Fibrillation | 1992 |
40 trial(s) available for sotalol and Recrudescence
Article | Year |
---|---|
Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Flutter; Cesarean Section; Digoxin; Female; Fetal Death; Fetal Diseases; Flecainide; Humans; Infant, Newborn; Injections, Intravenous; Japan; Natriuretic Peptide, Brain; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Care; Recurrence; Sotalol; Tachycardia; Tachycardia, Supraventricular; Umbilical Veins; Young Adult | 2019 |
Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Chi-Square Distribution; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Hypertension; Linear Models; Male; Middle Aged; Multivariate Analysis; Poland; Prospective Studies; Pulmonary Veins; Recurrence; Risk Factors; Sotalol; Time Factors; Treatment Outcome | 2014 |
Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
Topics: Defibrillators, Implantable; Female; Humans; Male; Metoprolol; Middle Aged; Prospective Studies; Recurrence; Sotalol; Tachycardia, Ventricular | 2002 |
Intracardiac low-energy versus transthoracic high-energy direct-current cardioversion of atrial fibrillation: a randomised comparison.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Biomarkers; Creatine Kinase; Electric Countershock; Female; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Random Allocation; Recurrence; Severity of Illness Index; Sotalol; Time Factors; Treatment Outcome; Troponin T | 2003 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Atrioventricular Node; Calcium Channel Blockers; Cardiac Surgical Procedures; Electric Countershock; Female; Heart Rate; Heart Ventricles; Humans; Length of Stay; London; Male; Middle Aged; Pilot Projects; Postoperative Complications; Procainamide; Propafenone; Prospective Studies; Recurrence; Sotalol; Survival Analysis; Treatment Outcome | 2003 |
Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Health Status Indicators; Humans; Propafenone; Prospective Studies; Quality of Life; Recurrence; Sotalol | 2003 |
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Safety; Sotalol | 2004 |
Amiodarone versus Sotalol and Propafenone for prevention of immediate recurrence of atrial fibrillation after internal cardioversion: importance of P wave analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Propafenone; Prospective Studies; Recurrence; Sotalol | 2006 |
An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; Lactic Acid; Magnesium Compounds; Male; Phenethylamines; Recurrence; Sotalol; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2006 |
Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Monitoring; Female; Flecainide; Follow-Up Studies; Humans; Inpatients; Long QT Syndrome; Male; Middle Aged; Phenethylamines; Propafenone; Recurrence; Sotalol; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome; Ventricular Function, Left; Withholding Treatment | 2007 |
Bifocal versus unifocal right atrial pacing under plasma level controlled sotalol to prevent atrial fibrillation in patients with symptomatic sinus bradycardia and paroxysmal atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Combined Modality Therapy; Cross-Over Studies; Electrocardiography; Electrodes, Implanted; Female; Follow-Up Studies; Heart Atria; Hemodynamics; Humans; Male; Middle Aged; Pacemaker, Artificial; Recurrence; Sick Sinus Syndrome; Single-Blind Method; Sinoatrial Node; Sotalol | 2007 |
Controlled trial of sotalol for one year after myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Random Allocation; Recurrence; Sotalol; Time Factors | 1982 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myocardial Infarction; Oxprenolol; Practolol; Propranolol; Recurrence; Sotalol; Timolol | 1982 |
The Beta-Blocker Heart Attack Trial in perspective.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Death, Sudden; Double-Blind Method; Female; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Norway; Placebos; Propranolol; Recurrence; Sotalol; Timolol | 1983 |
A controlled trial of sotalol for 1 year after myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Humans; Middle Aged; Myocardial Infarction; Random Allocation; Recurrence; Scotland; Sotalol | 1983 |
Results of Holter ECG guided therapy for ventricular arrhythmias: the ESVEM trial.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Death, Sudden, Cardiac; Electrocardiography, Ambulatory; Follow-Up Studies; Humans; Prospective Studies; Recurrence; Sodium Channel Blockers; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1994 |
[A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation].
Topics: Adult; Aged; Atrial Fibrillation; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Recurrence; Risk Factors; Sotalol; Time Factors | 1995 |
Risk factors for the development of recurrent atrial fibrillation: role of pacing and clinical variables.
Topics: Atrial Fibrillation; Cardiac Pacing, Artificial; Chronic Disease; Female; Heart Atria; Heart Diseases; Heart Rate; Heart Ventricles; Humans; Life Tables; Male; Middle Aged; Propafenone; Prospective Studies; Recurrence; Regression Analysis; Risk Factors; Sotalol; Stroke Volume; Treatment Failure | 1995 |
Hemodynamic effects of oral sotalol during both sinus rhythm and atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Echocardiography; Electrophysiology; Female; Hemodynamics; Humans; Male; Middle Aged; Recurrence; Sotalol; Tachycardia, Paroxysmal; Ventricular Function | 1993 |
Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
Topics: Actuarial Analysis; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Proportional Hazards Models; Prospective Studies; Recurrence; Sotalol; Tachycardia, Ventricular; Ventricular Fibrillation | 1993 |
Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Recurrence; Sotalol; Stroke Volume; Tachycardia, Ventricular | 1993 |
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol | 1993 |
Sotalol and type IA drugs in combination prevent recurrence of sustained ventricular tachycardia.
Topics: Aged; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Quinidine; Recurrence; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 1993 |
Multicenter comparative study of the efficacy and safety of sotalol in the prophylactic treatment of patients with paroxysmal supraventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Double-Blind Method; Drug Administration Schedule; Electrocardiography; Female; Humans; Life Tables; Male; Middle Aged; Recurrence; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Time Factors | 1997 |
[Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Echocardiography, Transesophageal; Female; Flecainide; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol | 1997 |
Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Recurrence; Safety; Sotalol; Stroke Volume; Treatment Outcome | 1998 |
[Analysis of atrial fibrillation recurrence during therapy with sotalol or quinidine. Researchers of +SOCESP].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Middle Aged; Quinidine; Recurrence; Sotalol | 1998 |
[Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Electric Countershock; Electrocardiography, Ambulatory; Germany; Humans; Prospective Studies; Quinidine; Recurrence; Sotalol; Tachycardia, Paroxysmal; Telemetry; Treatment Outcome; Verapamil | 1999 |
Efficacy and safety of sotalol versus quinidine for the maintenance of sinus rhythm after conversion of atrial fibrillation. SOCESP Investigators. The Cardiology Society of São Paulo.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Female; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Recurrence; Sotalol; Treatment Outcome | 1999 |
The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Magnesium Hydroxide; Male; Middle Aged; Recurrence; Safety; Sotalol | 2000 |
Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Electric Countershock; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Recurrence; Reproducibility of Results; Sotalol | 2000 |
Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.
Topics: Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Single-Blind Method; Sotalol | 2000 |
Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Digoxin; Drug Administration Routes; Electric Countershock; Electrocardiography; Female; Heart Rate; Humans; Length of Stay; Male; Pilot Projects; Procainamide; Prognosis; Propafenone; Prospective Studies; Recurrence; Sotalol | 2000 |
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm?
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Heart Rate; Humans; Male; Middle Aged; Propafenone; Recurrence; Risk Factors; Sotalol; Treatment Outcome | 2000 |
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Bisoprolol; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Recurrence; Sotalol; Treatment Outcome | 2001 |
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Humans; Italy; Longitudinal Studies; Male; Middle Aged; Propafenone; Recurrence; Sotalol; Treatment Outcome | 2001 |
Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Female; Health Status Indicators; Humans; Male; Mental Health; Propafenone; Quality of Life; Recurrence; Regression Analysis; Severity of Illness Index; Sotalol | 2002 |
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramide; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Flecainide; Humans; Hypotension; Injections, Intravenous; Lidocaine; Middle Aged; Recurrence; Sotalol; Tachycardia | 1990 |
Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.
Topics: Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Death, Sudden; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Heart Rate; Humans; Male; Middle Aged; Prognosis; Quinidine; Recurrence; Sotalol | 1990 |
Long-term experience with sotalol in the treatment of complex ventricular arrhythmias.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Drug Administration Schedule; Drug Evaluation; Electrocardiography; Female; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Sotalol | 1987 |
39 other study(ies) available for sotalol and Recrudescence
Article | Year |
---|---|
Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Topics: Action Potentials; Adrenergic beta-Antagonists; Age Factors; Anti-Arrhythmia Agents; Digoxin; Drug Therapy, Combination; Female; Flecainide; Heart Rate; Humans; Infant; Infant, Newborn; Male; Nadolol; Recurrence; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Time Factors; Treatment Outcome; Voltage-Gated Sodium Channel Blockers | 2021 |
Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Sotalol | 2014 |
Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cohort Studies; Dronedarone; Female; Humans; Male; Patient Admission; Pennsylvania; Phenethylamines; Recurrence; Retrospective Studies; Sotalol; Stroke; Sulfonamides | 2016 |
Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
Topics: Adult; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter Ablation; Combined Modality Therapy; Drug Monitoring; Drug Therapy, Combination; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Male; Metoprolol; Middle Aged; Recurrence; Sotalol; Treatment Outcome | 2017 |
Mortality and reinfarction among patients using different beta-blockers for secondary prevention after a myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Bisoprolol; Female; Humans; Kaplan-Meier Estimate; Male; Metoprolol; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Recurrence; Registries; Sotalol | 2009 |
[Next cardioversion or RF ablation in professional driver with recurrent typical atrial flutter and MAS syndromes].
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Automobile Driving; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Humans; Hypertension; Male; Obesity; Recurrence; Sotalol; Treatment Outcome | 2009 |
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Hypertrophic; Carvedilol; Continuous Positive Airway Pressure; Defibrillators, Implantable; Heart Failure; Humans; Lung Diseases, Interstitial; Male; Propanolamines; Recurrence; Sleep Apnea Syndromes; Sotalol; Tachycardia, Ventricular | 2009 |
Atrial fibrillation degenerates into ventricular fibrillation.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Defibrillators, Implantable; Disease Progression; Electrocardiography; Humans; Male; Metoprolol; Recurrence; Signal Processing, Computer-Assisted; Sotalol; Ventricular Fibrillation; Ventricular Premature Complexes | 2010 |
First time and repeat cardioversion of atrial tachyarrhythmias - a comparison of outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Humans; Male; Recurrence; Retreatment; Retrospective Studies; Sotalol; Tachycardia; Treatment Outcome | 2010 |
Intraosseous infusion is unreliable for adenosine delivery in the treatment of supraventricular tachycardia.
Topics: Adenosine; Amiodarone; Catheterization, Central Venous; Combined Modality Therapy; Drug Therapy, Combination; Emergencies; Humans; Infant; Infusions, Intraosseous; Infusions, Intravenous; Male; Procainamide; Propranolol; Recurrence; Sotalol; Tachycardia, Supraventricular; Treatment Failure; Vagus Nerve Stimulation | 2012 |
Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Prospective Studies; Recurrence; Regression Analysis; Risk Assessment; Sotalol; Time Factors | 2003 |
Electrophysiologic study-guided therapy with sotalol for life-threatening ventricular tachyarrhythmias.
Topics: Aged; Analysis of Variance; Anti-Arrhythmia Agents; Chi-Square Distribution; Defibrillators, Implantable; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Sotalol; Tachycardia, Ventricular; Treatment Outcome | 2005 |
Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Middle Aged; Recurrence; Sotalol; Time Factors; Torsades de Pointes | 2005 |
Rate of conversion and recurrence after sotalol treatment in patients with direct current-refractory atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Electric Countershock; Female; Heart Rate; Humans; Male; Middle Aged; Premedication; Prospective Studies; Recurrence; Sotalol; Treatment Outcome | 2006 |
[Conversion in sinus rhythm].
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Differential; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Middle Aged; Recurrence; Sotalol; Sympatholytics | 2006 |
Differential effects of sotalol and metoprolol on induction of paroxysmal supraventricular tachycardia.
Topics: Adult; Aged; Atrioventricular Node; Female; Humans; Male; Metoprolol; Middle Aged; Recurrence; Sotalol; Tachycardia, Paroxysmal | 1984 |
Sotalol for atrial tachycardias after surgery for congenital heart disease.
Topics: Administration, Oral; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Bradycardia; Cardiac Pacing, Artificial; Child; Disease-Free Survival; Electric Countershock; Electrocardiography; Fatigue; Follow-Up Studies; Heart Atria; Heart Defects, Congenital; Heart Rate; Humans; Pacemaker, Artificial; Postoperative Complications; Recurrence; Sick Sinus Syndrome; Sotalol; Survival Rate; Tachycardia; Time Factors; Treatment Outcome | 1997 |
Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Middle Aged; Multivariate Analysis; Recurrence; Sotalol; Treatment Outcome | 1997 |
Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Sotalol; Time Factors | 1998 |
Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
Topics: Anti-Arrhythmia Agents; Electrophysiology; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Reproducibility of Results; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 1999 |
Incidence and modes of onset of early reinitiation of atrial fibrillation after successful internal cardioversion, and its prevention by intravenous sotalol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Electric Countershock; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Sotalol | 1999 |
Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Electrocardiography; Electrodes, Implanted; Female; Heart Atria; Humans; Infusions, Intravenous; Male; Middle Aged; Premedication; Recurrence; Sotalol | 2000 |
[Paroxysmal atrial fibrillation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Female; Humans; Middle Aged; Monitoring, Physiologic; Pacemaker, Artificial; Prognosis; Quinidine; Recurrence; Risk Factors; Sotalol; Thromboembolism; Vasodilator Agents | 2000 |
Sotalol in the treatment of fetal dysrhythmias.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Follow-Up Studies; Humans; Hydrops Fetalis; Infant, Newborn; Maternal-Fetal Exchange; Morbidity; Pregnancy; Recurrence; Retrospective Studies; Sotalol; Tachycardia, Supraventricular; Treatment Outcome | 2000 |
The frequency analysis of signal-averaged ECG of P wave as predictor of efficacy of class III antiarrhythmic drugs to maintain sinus rhythm in recurrent idiopathic atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Recurrence; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Sotalol; Treatment Outcome | 2001 |
Global distribution of atrial ectopic foci triggering recurrence of atrial tachyarrhythmia after electrical cardioversion of long-standing atrial fibrillation: a bi-atrial basket mapping study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol; Tachycardia, Ectopic Atrial | 2001 |
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Topics: Anti-Arrhythmia Agents; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Infant; Infant Welfare; Infant, Newborn; Male; Recurrence; Sotalol; Tachycardia, Supraventricular; Texas; Treatment Outcome; Ventricular Function, Left; Wolff-Parkinson-White Syndrome | 2002 |
[Atrial fibrillation successfully converted. A new standard in the prevention of recurrence?].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Calcium Channel Blockers; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Humans; Placebos; Quinidine; Randomized Controlled Trials as Topic; Recurrence; Sotalol; Time Factors; Verapamil | 2001 |
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Male; Middle Aged; Recurrence; Regression Analysis; Sotalol; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Sotalol-induced torsade de pointes: management with magnesium infusion.
Topics: Aged; Amiodarone; Atrial Fibrillation; Dose-Response Relationship, Drug; Electrocardiography, Ambulatory; Female; Humans; Magnesium Sulfate; Recurrence; Sotalol; Torsades de Pointes | 1992 |
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.
Topics: Actuarial Analysis; Aged; Amiodarone; Analysis of Variance; Atrial Fibrillation; Atrial Flutter; Chronic Disease; Drug Administration Schedule; Electric Countershock; Female; Flecainide; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Quinidine; Recurrence; Sotalol | 1991 |
Sotalol in patients with life-threatening ventricular tachyarrhythmias.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Angiography; Coronary Disease; Electric Stimulation; Electrocardiography, Ambulatory; Female; Heart Ventricles; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Recurrence; Sotalol; Tachycardia; Ventricular Fibrillation | 1990 |
Safety and efficacy of sotalol in patients with drug-refractory sustained ventricular tachyarrhythmias.
Topics: Cardiac Pacing, Artificial; Female; Heart Ventricles; Humans; Male; Middle Aged; Recurrence; Sotalol; Tachycardia; Time Factors | 1990 |
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs.
Topics: Adult; Aged; Atrial Fibrillation; Atrial Flutter; Data Interpretation, Statistical; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Propafenone; Recurrence; Sotalol | 1990 |
Inadvertent catheter-induced right bundle branch block in a patient with preexistent left bundle branch block and recurrent macroreentrant ventricular tachycardia.
Topics: Aged; Amiodarone; Bundle-Branch Block; Cardiac Catheterization; Electric Stimulation; Electrocardiography; Heart Ventricles; Humans; Male; Recurrence; Sotalol; Tachycardia | 1989 |
Low-dose oral sotalol for monomorphic ventricular tachycardia: effects during programmed electrical stimulation and follow-up.
Topics: Administration, Oral; Adult; Aged; Cardiac Pacing, Artificial; Chronic Disease; Drug Evaluation; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Sotalol; Tachycardia; Ventricular Fibrillation | 1989 |
Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
Topics: Aged; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Sotalol; Stroke Volume; Tachycardia; Ventricular Fibrillation | 1989 |
Clinical experience with sotalol in patients with drug-refractory ventricular arrhythmias.
Topics: Administration, Oral; Arrhythmias, Cardiac; Drug Resistance; Electric Countershock; Electrophysiology; Heart Diseases; Heart Ventricles; Humans; Recurrence; Sotalol | 1989 |
Oral sotalol in neonatal supraventricular tachycardia.
Topics: Humans; Infant, Newborn; Recurrence; Sotalol; Tachycardia, Supraventricular | 1988 |